ANI Pharmaceuticals
ANIP
#4828
Rank
HK$14.35 B
Marketcap
HK$639.09
Share price
0.12%
Change (1 day)
38.96%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total debt

Total debt on the balance sheet as of September 2025 : HK$4.82 Billion

According to ANI Pharmaceuticals's latest financial reports the company's total debt is HK$4.82 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ANI Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$4.84 B117.16%
2023-12-31HK$2.23 B-0.34%
2022-12-31HK$2.23 B-0.1%
2021-12-31HK$2.24 B55.67%
2020-12-31HK$1.43 B-0.49%
2019-12-31HK$1.44 B0.94%
2018-12-31HK$1.43 B-8.97%
2017-12-31HK$1.57 B68.29%
2016-12-31HK$0.93 B6.41%
2015-12-31HK$0.87 B6.39%
2014-12-31HK$0.82 B
2013-12-31N/A-100%
2012-12-31HK$61.1 M-54.62%
2011-12-31HK$0.13 B-6.71%
2010-12-31HK$0.14 B11.63%
2009-12-31HK$0.12 B
2000-12-31HK$3.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Jazz Pharmaceuticals
JAZZ
HK$42.24 B 775.13%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
HK$39.9 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$132.85 B 2,652.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
HK$473.48 B 9,709.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
HK$4.97 B 3.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$20.39 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
HK$70.28 B 1,356.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$249.17 B 5,062.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
HK$69.61 B 1,342.14%๐Ÿ‡ฌ๐Ÿ‡ง UK